Drug Interaction Assessment and Modification of Therapy

A drug interaction occurs when one substance changes the effect of another, for example by altering how much active drug is present or how strongly it acts. Assessing interactions means recognizing which combinations are clinically meaningful and understanding how a therapeutic plan may be reconsidered in their light.

Definition

A drug interaction is a change in the effect or disposition of one drug caused by the presence of another drug, food, or substance; interaction assessment is the process of identifying such interactions and judging their clinical significance so that therapy can be reconsidered where warranted.

Scope

This entry covers the mechanisms by which drugs interact, the distinction between interactions that are clinically important and those that are not, and the conceptual basis for modifying therapy. It treats interaction assessment as a methodological topic in pharmacotherapy optimization and does not provide management instructions, dose adjustments, or combination-specific recommendations.

Core questions

• By what mechanisms does one substance alter the effect or disposition of another?
• What distinguishes a clinically important interaction from a theoretical one?
• How is the clinical significance of a potential interaction judged?
• On what basis might a therapeutic plan be reconsidered when an interaction is identified?

Key concepts

• Pharmacokinetic interaction
• Pharmacodynamic interaction
• Enzyme induction and inhibition
• Clinical significance and severity
• Object and precipitant drugs
• Polypharmacy
• Interaction screening tools

Key theories

Pharmacokinetic versus pharmacodynamic interaction

Interactions are conventionally grouped into pharmacokinetic types, in which one drug changes the absorption, distribution, metabolism, or elimination of another and hence its concentration, and pharmacodynamic types, in which drugs acting on the same or related systems combine to alter effect without necessarily changing concentration.

Mechanisms

Interactions arise through two broad routes. In pharmacokinetic interactions, one drug changes the absorption, distribution, metabolism, or elimination of another, often by inducing or inhibiting metabolizing enzymes and thereby shifting the active concentration achieved (Wilkinson, 2005). In pharmacodynamic interactions, drugs that act on the same or related physiological systems combine, additively or oppositionally, to change the overall effect; the serotonin syndrome arising from combined serotonergic agents is a recognized example (Boyer & Shannon, 2005). Whether an interaction matters clinically depends on the drugs' properties, the magnitude of the change, and patient factors, and not every theoretically possible interaction is clinically significant (Edwards & Aronson, 2000).

Clinical relevance

Interaction assessment is a core function of clinical pharmacy and a recognized element of medication safety, particularly where multiple medicines are used. This entry describes how interactions are classified and how their significance is reasoned about; it is reference and educational material and is not a basis for managing, adjusting, or combining medicines for any individual.

Epidemiology

Adverse drug reactions, including those arising from interactions, are an established cause of hospital admission. A large prospective analysis found adverse drug reactions to be responsible for a notable share of admissions, with a substantial proportion judged potentially avoidable, underscoring why interaction assessment is treated as part of medication safety (Pirmohamed et al., 2004).

Evidence & guidelines

The mechanistic basis of interactions is grounded in clinical pharmacology (Wilkinson, 2005), and the framing of interactions within adverse-reaction surveillance reflects pharmacovigilance practice (Edwards & Aronson, 2000). Interaction databases, screening software, and product labeling provide the specific, combination-level significance ratings and management options, which fall outside this reference entry.

History

As clinical pharmacology clarified how drugs are metabolized and how metabolizing enzymes can be induced or inhibited, the mechanistic understanding of pharmacokinetic interactions matured (Wilkinson, 2005). Recognition that adverse drug reactions, including interactions, are a major and partly avoidable cause of harm (Pirmohamed et al., 2004; Edwards & Aronson, 2000) drove the development of systematic interaction screening within medication-safety practice.

Debates

How should interaction alerts be calibrated?

Automated screening can flag large numbers of potential interactions, but excessive low-value alerts can lead to alert fatigue; how to prioritize clinically significant interactions without overwhelming users is an ongoing question in medication safety.

Key figures

• Grant Wilkinson
• Munir Pirmohamed
• Jeffrey Aronson

Seminal works

• wilkinson-2005
• pirmohamed-2004
• edwards-2000

Frequently asked questions

What is the difference between a pharmacokinetic and a pharmacodynamic drug interaction?

A pharmacokinetic interaction changes how much active drug is present by altering absorption, distribution, metabolism, or elimination, whereas a pharmacodynamic interaction changes the effect of drugs acting on the same or related systems without necessarily changing their concentration.

Are all drug interactions clinically important?

No. Many possible interactions are minor or theoretical; clinical significance depends on the drugs involved, the size of the effect, and patient factors, which is why interactions are assessed for importance rather than treated uniformly.